Skip to content
Back

Optimising treatments of STIs using pharmacokinetics

Optimising treatments of STIs using pharmacokinetics

University of Melbourne · Australia

Who it is for

  • Skip to main content Scholar hip Optimi ing treatment of STI u ing pharmacokinetic Scholar hip Optimi ing treatment of STI u ing pharmacokinetic Application i required.
  • Check eligibility Key cholar hip detail Application tatu Not open yet Application open 1 Jan 2020 Eligible tudy level Graduate re earch Eligible tudent type Dome tic and international tudent Eligible tudy tage Future tudy Benefit duration One or more year Summary The Sexual Health Unit, in the Centre for Epidemiology and Bio tati tic ,
  • Melbourne School of Population and Global Health, i eeking a talented tudent to undertake re earch into developing pharmacokinetic method to optimize the treatment of exually tran mitted infection (STI ) and prevent the emergence of antimicrobial re i tance (AMR).
  • There i a particular focu on gonorrhoea a thi con idered a global threat by the World Health Organi ation (WHO).
  • The Centre ha one cholar hip for an appropriately qualified tudent to commence re earch in 2021.The Sexual Health Unit Benefit The Centre i offering one cholar hip for a tudent to thi re earch project.
  • You will receive the equivalent of an Au tralian Government Re earch Training Program Scholar hip which provide a fortnightly tipend.Further detail on the tipend and cholar hip term are available.
  • Duration: One or more year Eligibility and election criteria Eligibility Applicant are required to meet the Univer ity of Melbourne’ requirement for a Re earch Higher Degree candidature.Plea e refer to:http :// tudy.unimelb.edu.au/find/cour e /graduate/doctor-of-philo ophy-medicine-denti try-and-health- cience /entry-requirement / Selection
  • criteria You will have ucce fully obtained an Honour or Ma ter Degree (or equivalent) and you will need to be an Au tralian or New Zealand citizen or an Au tralian permanent

Key facts

Award value
Living stipend
Covers
Living costs
Funding type
Living stipend
Level
Doctoral
Fields
Medicine
Renewable
Yes
Provider
University of Melbourne

Figures as stated by the provider. Confirm the current round on the official page before applying.

Good to know

Skip to main content Scholar hip Optimi ing treatment of STI u ing pharmacokinetic Scholar hip Optimi ing treatment of STI u ing pharmacokinetic Application i required. Check eligibility Key cholar hip detail Application tatu Not open yet Application open 1 Jan 2020 Eligible tudy level Graduate re earch Eligible tudent type Dome tic and international tudent Eligible tudy tage Future tudy Benefit duration One or more year Summary The Sexual Health Unit, in the Centre for Epidemiology and Bio tati tic , Melbourne School of Population and Global Health, i eeking a talented tudent to undertake re earch into developing pharmacokinetic method to optimize the treatment of exually tran mitted infection (STI ) and prevent the emergence of antimicrobial re i tance (AMR). There i a particular focu on gonorrhoea a thi con idered a global threat by the World Health Organi ation (WHO). The Centre ha one cholar hip for an appropriately qualified tudent to commence re earch in 2021.The Sexual Health Unit Benefit The Centre i offering one cholar hip for a tudent to thi re earch project. You will receive the equivalent of an Au tralian Government Re earch Training Program Scholar hip which provide a fortnightly tipend.Further detail on the tipend and cholar hip term are available. Duration: One or more year Eligibility and election criteria Eligibility Applicant are required to meet the Univer ity of Melbourne’ requirement for a Re earch Higher Degree candidature.Plea e refer to:http :// tudy.unimelb.edu.au/find/cour e /graduate/doctor-of-philo ophy-medicine-denti try-and-health- cience /entry-requirement / Selection criteria You will have ucce fully obtained an Honour or Ma ter Degree (or equivalent) and you will need to be an Au tralian or New Zealand citizen or an Au tralian permanent Exact official public evidence revalidated 2026-09-11, unsupported precision omitted.

Facts checked against the official source. Last updated 15 September 2026.